CCL2 and Atherosclerotic lesion: In this regard it has been established that inhibition of MCP-1 reduces macrophage levels in atherosclerotic lesions, and blocking VCAM-1 inhibits monocytes from entering the arterial wall (Huo et al., 2000; Inoue et al., 2002).